A.S.P.E.N. Clinical Guidelines: Nutrition Support of the Critically Ill Child

This is a clinical practice guideline, not a single experiment. The authors systematically reviewed existing literature across multiple domains of nutrition support in critically ill children:

**Nutrition assessment methods:** Screening tools, anthropometric measurements (weight, mid-arm circumference), and biochemical markers (albumin, prealbumin) to identify malnutrition

**Energy expenditure estimation:** Predictive equations (e.g., Schofield, Harris-Benedict, WHO) versus indirect calorimetry (measured resting energy expenditure)

**Macronutrient composition:** Optimal proportions of protein, carbohydrates, and fats

**Route of feeding:** Enteral nutrition (EN; feeding via the gut, either orally or through a tube) versus parenteral nutrition (PN; intravenous feeding)

**Timing of initiation:** Early versus delayed nutrition support

**Immune-modulating nutrients:** Specific additives like glutamine, arginine, omega-3 fatty acids, and antioxidants

The outcome measures included: mortality, length of PICU stay, length of hospital stay, duration of mechanical ventilation, infectious complications, anthropometric changes (weight, mid-arm circumference), and metabolic complications (hyperglycemia, overfeeding, underfeeding).

This guideline synthesized data from multiple studies involving critically ill children admitted to PICUs. The specific populations varied by study, but included:

**Age range:** Neonates through adolescents (though neonatal-specific guidelines were published separately)

**Sample sizes across studies:** Ranged from small case series (n < 20) to larger cohort studies (n > 200)

**Conditions:** Medical, surgical, and trauma patients; burn victims; post-cardiac surgery patients; sepsis; respiratory failure

**Setting:** Pediatric intensive care units in academic medical centers, primarily in North America and Europe

**Key prevalence data:** Leite et al reported 65% prevalence of malnutrition on PICU admission (n = 275), with increased mortality in malnourished children

No single study enrolled healthy volunteers or adults; the guideline explicitly warns against extrapolating adult critical care data to children.

The guideline evaluated studies using multiple measurement approaches:

**Anthropometrics:** Weight (kg), mid-arm circumference (cm), triceps skinfold thickness (mm), and height/length. These were compared to standardized growth charts (e.g., WHO, CDC). Weight changes were interpreted cautiously due to fluid shifts from IV fluids and diuresis.

**Biochemical markers:** Serum albumin (half-life 14–20 days), serum prealbumin/transthyretin (half-life 24–48 hours), C-reactive protein (CRP, acute-phase marker), and nitrogen balance (calculated as nitrogen intake minus urinary nitrogen excretion)

**Energy expenditure:** Indirect calorimetry (IC) using metabolic carts that measure oxygen consumption (VO₂) and carbon dioxide production (VCO₂) to calculate resting energy expenditure (REE) via the Weir equation. Predictive equations included Schofield, Harris-Benedict, WHO, and White equations.

**Clinical outcomes:** Mortality (all-cause, in-hospital), length of PICU stay (days), length of hospital stay (days), duration of mechanical ventilation (days), infectious complications (bloodstream infections, pneumonia, urinary tract infections), and feeding tolerance (gastric residual volumes, vomiting, diarrhea, abdominal distension)

**Energy balance:** Calculated as energy delivered minus energy expended, with deficits >20% of requirements considered clinically significant

**Study design:** This is a clinical practice guideline developed by the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), following Institute of Medicine standards for systematic evidence review. The authors conducted literature searches using Medline, the Cochrane Central Registry of Controlled Trials, and the Cochrane Database of Systematic Reviews. Each recommendation was graded using a predefined evidence hierarchy (Table 1 in the paper):

**Grade A:** Supported by at least two Level I investigations (large, well-powered RCTs)

**Grade B:** Supported by one Level I investigation

**Grade C:** Supported by Level II investigations (small RCTs with uncertain results)

**Grade D:** Supported by Level III investigations (nonrandomized cohort with contemporaneous controls)

**Grade E:** Supported by Level IV (nonrandomized cohort with historical controls) or Level V (case series, uncontrolled studies, expert opinion) evidence

**Key methodological features:**

**Systematic review process:** Authors completed thorough literature reviews, chapter editors ensured compliance with formatting, internal and external peer review occurred, and the A.S.P.E.N. Board of Directors provided final approval

**Evidence grading:** Each recommendation was explicitly linked to the strength of supporting evidence, allowing readers to judge confidence in the guidance

**Transparency:** The guideline explicitly states when recommendations are based on weak evidence or expert opinion alone

**What this design can prove:**

The guideline can identify where strong evidence exists (virtually nowhere in pediatric critical care nutrition) and where gaps remain

It can synthesize findings across multiple small studies to suggest best practices

It can highlight consistent patterns (e.g., malnutrition prevalence, energy deficits) across different settings

**What this design cannot prove:**

It cannot establish causality between nutrition interventions and clinical outcomes because most supporting studies were observational (cohort or case series)

It cannot provide precise effect sizes for specific interventions because the underlying studies were heterogeneous in populations, interventions, and outcomes

It cannot rule out confounding by indication (e.g., sicker children may receive different nutrition, making it impossible to separate the effect of nutrition from the effect of illness severity)

The guideline itself is not a primary research study; it is a summary of existing evidence, so its conclusions are only as strong as the underlying studies

**Major methodological weaknesses:**

**Overwhelmingly weak evidence:** Of the 17 guideline recommendations, the vast majority received Grade D or E (supported by cohort studies, case series, or expert opinion). Only a handful reached Grade C (small RCTs). None achieved Grade A or B.

**Heterogeneity of studies:** Studies varied widely in patient populations (age, diagnosis, severity), interventions (type of formula, timing, route), and outcome definitions, making meta-analysis impossible for most questions

**Publication bias:** The guideline did not formally assess publication bias, and negative studies may be underrepresented

**Outdated evidence base:** Published in 2009, the literature search would have captured studies through approximately 2007–2008. Many newer trials have since been conducted.

**Conflict of interest:** The guideline was developed by A.S.P.E.N., an organization with ties to the nutrition support industry (formula manufacturers, feeding tube companies), though specific conflicts were not detailed for individual authors

**Lack of blinding:** Most included studies were unblinded, introducing performance and detection bias

**Small sample sizes:** Many pediatric studies had fewer than 50 patients, making them underpowered to detect clinically meaningful differences in mortality or complications

**Nutrition assessment:**

Malnutrition prevalence on PICU admission: 65% in one large cohort (Leite et al., n = 275), with increased mortality in malnourished children

Energy deficits during PICU stay correlated with deterioration in mid-arm circumference and weight (Hulst et al.)

Anthropometric abnormalities accrued during PICU admission returned to normal by 6 months after discharge in survivors

Albumin was deemed unreliable as a nutrition marker due to its long half-life (14–20 days) and confounding by inflammation, fluid status, and liver disease

Prealbumin (half-life 24–48 hours) was considered a better marker of visceral protein status, but still confounded by inflammation and renal failure

**Energy expenditure:**

Predictive equations (Schofield, Harris-Benedict, WHO, White) were frequently inaccurate in critically ill children, with errors ranging from –30% to +50% of measured REE

Indirect calorimetry was identified as the gold standard but was not widely available in PICUs

Both underfeeding (energy deficits >20% of requirements) and overfeeding (energy provision >110% of requirements) were common, each occurring in 30–50% of patients depending on the study

**Route of feeding:**

Enteral nutrition (EN) was recommended as the preferred route when the gastrointestinal tract was functional, based on physiological rationale and adult data showing reduced infectious complications compared to parenteral nutrition (PN)

However, no high-quality pediatric RCT directly compared EN to PN for mortality or major complications

Barriers to EN in the PICU included: hemodynamic instability, need for vasopressors, gastrointestinal intolerance (high gastric residuals, vomiting, diarrhea), and frequent interruptions for procedures or extubation

**Timing of initiation:**

No strong evidence supported early (<24–48 hours) versus delayed enteral feeding in critically ill children

Adult data (not directly applicable) suggested early EN may reduce infectious complications but increase risk of gastrointestinal intolerance

**Immune-modulating nutrients:**

Insufficient pediatric data to recommend routine use of glutamine, arginine, omega-3 fatty acids, or antioxidants in critically ill children

Some adult studies showed potential benefit in specific populations (e.g., glutamine in burn patients), but pediatric trials were lacking

**Overall evidence quality:**

The guideline explicitly states: "The lack of systematic research and clinical trials on various aspects of nutrition support in the PICU is striking and makes it challenging to compile evidence based practice guidelines"

Most recommendations were Grade D or E, meaning they were supported by nonrandomized cohort studies, case series, or expert opinion alone

Because this is a guideline rather than a single study, precise effect sizes are not available for most recommendations. However, the following contextual translations can be made:

**Malnutrition prevalence:** 65% of children admitted to the PICU were malnourished—meaning roughly 2 out of every 3 critically ill children had some degree of nutritional deficit at the time of admission. This is comparable to the rate of vitamin D deficiency in northern latitudes during winter.

**Energy equation inaccuracy:** Predictive equations could be off by as much as 50% in either direction. For a child whose true energy needs are 1,000 kcal/day, a predictive equation might recommend anywhere from 500 to 1,500 kcal/day—the difference between starvation and overfeeding.

**Energy deficits:** Children who accumulated energy deficits >20% of requirements showed measurable loss of muscle mass (mid-arm circumference decline). Over a 7-day PICU stay, this could represent a cumulative deficit of 1,400–2,800 kcal for a school-aged child—roughly equivalent to skipping 2–4 full days of meals.

**Recovery of anthropometrics:** The anthropometric abnormalities that developed during PICU admission resolved by 6 months after discharge in survivors, suggesting that the nutritional impact of critical illness is reversible in children who recover.

**What the authors acknowledge:**

"The lack of systematic research and clinical trials on various aspects of nutrition support in the PICU is striking"

"Extrapolation of data from adult critical care literature is not desirable"

Many recommendations are based on "expert opinion alone" (Grade E)

Weight changes during PICU stay must be interpreted cautiously due to fluid shifts

**What a critical reader would note:**

**Outdated evidence:** Published in 2009, the literature search ended around 2007–2008. Major pediatric critical care nutrition trials (e.g., PEPaNIC trial, 2016) were published after this guideline.

**Industry influence:** A.S.P.E.N. receives funding from nutrition support companies (Abbott, Baxter, Nestlé Health Science, etc.), and guideline authors may have conflicts of interest that were not fully disclosed in this publication.

**No formal meta-analysis:** The guideline did not pool data across studies to generate summary effect sizes, limiting the precision of its conclusions.

**Heterogeneity of PICU populations:** A 2-year-old with sepsis is physiologically very different from a 16-year-old with traumatic brain injury. The guideline treats "critically ill children" as a homogeneous group, which may obscure important subgroup differences.

**Lack of blinding in most studies:** Feeding interventions are difficult to blind (you know if you're getting tube feeds vs. IV nutrition), introducing performance bias.

**Survivor bias:** Studies reporting recovery of anthropometrics at 6 months only included survivors. Children who died may have had worse nutritional trajectories that were not captured.

**No cost-effectiveness analysis:** The guideline does not discuss whether implementing its recommendations (e.g., indirect calorimetry for all patients) would be cost-effective or feasible in resource-limited settings.

**Limited generalizability:** Most studies were conducted in academic medical centers in high-income countries. Results may not apply to community hospitals or low-resource settings.

For someone running their own n=1 experiment (e.g., optimizing nutrition during recovery from illness or surgery):

### What to test

**Energy intake matching:** Test whether using a measured energy expenditure (via indirect calorimetry or a validated wearable) versus a predictive equation changes your energy balance, weight stability, and recovery speed

**Protein intake:** Test whether increasing protein intake to 1.5–2.5 g/kg/day (the range suggested for critically ill children, scaled to your body weight) improves muscle preservation or recovery time

**Feeding route:** If you have a functional gut, test whether enteral nutrition (oral or tube feeding) leads to fewer complications (e.g., infections, metabolic disturbances) compared to relying on IV nutrition

**Timing of feeding:** Test whether initiating nutrition within 24 hours of illness/injury versus waiting 48–72 hours affects your recovery trajectory

### Minimum meaningful duration

**For energy balance studies:** At least 5–7 days to accumulate a measurable energy deficit or surplus (the guideline found deficits accrued over days, not hours)

**For anthropometric changes:** At least 2–4 weeks to see measurable changes in weight or muscle mass (mid-arm circumference changes were detectable over a PICU stay of ~7–14 days)

**For recovery studies:** At least 6 months to assess full nutritional recovery (the guideline found anthropometric abnormalities resolved by 6 months post-discharge)

### What to measure

**Primary metric:** Daily energy intake (kcal) versus estimated energy expenditure (use a metabolic cart if available, or a validated wearable like a SenseWear armband or indirect calorimetry device)

**Secondary metrics:**

- Body weight (daily, at same time of day, after voiding, in minimal clothing)

- Mid-arm circumference (weekly, using a non-stretch tape measure at the midpoint between acromion and olecranon)

- Subjective recovery rating (daily 0–10 scale: 0 = bedridden, 10 = fully recovered)

- Nitrogen balance (if feasible: collect 24-hour urine for urea nitrogen, calculate as protein intake/6.25 minus urinary urea nitrogen + 4 g for insensible losses)

**Confounders to track:**

- Fluid intake and output (to interpret weight changes)

- Inflammation markers (CRP, if available—inflammation increases energy expenditure and confounds prealbumin)

- Activity level (steps per day via pedometer or phone)

- Medications (steroids increase catabolism; sedatives decrease energy expenditure)

### Key confounds to control for

**Fluid status:** Weight changes during illness are often due to fluid shifts, not fat or muscle gain/loss. Track urine output, edema, and IV fluid intake.

**Inflammation:** Acute illness increases resting energy expenditure by 10–30% and suppresses prealbumin independent of nutrition status. Measure CRP to adjust interpretation.

**Activity level:** Bed rest causes muscle wasting even with adequate nutrition. Track steps or activity minutes daily.

**Medications:** Corticosteroids, vasopressors, and sed